GARDANI, GIANSTEFANO
 Distribuzione geografica
Continente #
NA - Nord America 3.423
AS - Asia 1.636
EU - Europa 1.355
SA - Sud America 209
Continente sconosciuto - Info sul continente non disponibili 92
AF - Africa 37
OC - Oceania 7
Totale 6.759
Nazione #
US - Stati Uniti d'America 3.218
SG - Singapore 608
CN - Cina 427
DE - Germania 278
IT - Italia 232
RU - Federazione Russa 186
CA - Canada 181
VN - Vietnam 175
HK - Hong Kong 162
BR - Brasile 144
SE - Svezia 135
IE - Irlanda 129
UA - Ucraina 123
FR - Francia 64
BD - Bangladesh 59
IN - India 56
GB - Regno Unito 47
FI - Finlandia 42
AT - Austria 41
DK - Danimarca 26
KR - Corea 22
PK - Pakistan 21
AR - Argentina 19
IQ - Iraq 19
MX - Messico 16
JP - Giappone 15
ID - Indonesia 13
CO - Colombia 12
TR - Turchia 12
EG - Egitto 9
ES - Italia 9
NL - Olanda 9
SA - Arabia Saudita 9
CL - Cile 8
EC - Ecuador 8
VE - Venezuela 7
BE - Belgio 5
DZ - Algeria 5
MA - Marocco 5
PL - Polonia 5
PY - Paraguay 5
TW - Taiwan 5
UZ - Uzbekistan 5
ZA - Sudafrica 5
AU - Australia 4
BG - Bulgaria 4
BY - Bielorussia 4
EU - Europa 4
KE - Kenya 4
TH - Thailandia 4
TN - Tunisia 4
CH - Svizzera 3
CR - Costa Rica 3
HU - Ungheria 3
MY - Malesia 3
NP - Nepal 3
NZ - Nuova Zelanda 3
PE - Perù 3
UY - Uruguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AZ - Azerbaigian 2
EE - Estonia 2
ET - Etiopia 2
HR - Croazia 2
IR - Iran 2
JO - Giordania 2
PH - Filippine 2
RO - Romania 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BB - Barbados 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
IL - Israele 1
JM - Giamaica 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
MD - Moldavia 1
MM - Myanmar 1
MN - Mongolia 1
MT - Malta 1
PS - Palestinian Territory 1
PT - Portogallo 1
SC - Seychelles 1
SN - Senegal 1
Totale 6.674
Città #
Singapore 395
Ashburn 366
Ann Arbor 339
Woodbridge 201
San Jose 200
Chandler 187
Frankfurt am Main 157
Hong Kong 152
Houston 139
Fairfield 134
Toronto 133
Jacksonville 126
Dublin 125
Dearborn 123
Wilmington 96
Milan 92
New York 83
Beijing 75
Shanghai 58
Los Angeles 56
The Dalles 55
Chicago 54
Council Bluffs 52
Seattle 51
Ho Chi Minh City 47
Princeton 46
Hanoi 44
Nanjing 40
Dallas 32
Cambridge 30
Buffalo 28
Vienna 28
Lauterbourg 25
Santa Clara 23
Lachine 22
Lawrence 22
Hefei 21
Altamura 20
Rome 20
Seoul 19
Helsinki 18
Nanchang 17
Falls Church 14
Moscow 14
Tianjin 14
Chennai 13
Nuremberg 13
Columbus 12
San Diego 11
São Paulo 11
Tokyo 11
Washington 11
Hangzhou 10
Orem 10
Shenyang 10
Biên Hòa 9
Changsha 9
Guangzhou 9
Jinan 9
Andover 8
Brooklyn 8
Da Nang 8
Hebei 8
Montreal 8
Munich 8
San Francisco 8
Dhaka 7
Kunming 7
Mountain View 7
Phoenix 7
Atlanta 6
Baghdad 6
Belo Horizonte 6
Detroit 6
Istanbul 6
Jiaxing 6
Boardman 5
Brasília 5
Brussels 5
Edmonton 5
Elk Grove Village 5
Haiphong 5
Lahore 5
Miami 5
Norwalk 5
Nürnberg 5
Santiago 5
Tashkent 5
University Park 5
Zhengzhou 5
Amsterdam 4
Bonndorf 4
Central 4
Denver 4
Dong Ket 4
Düsseldorf 4
Figino 4
Guayaquil 4
Huizen 4
Hải Dương 4
Totale 4.371
Nome #
In haematopoietic SCT for acute leukemia TBI impacts on relapse but not survival: results of a multicentre observational study 444
Change in glucose metabolism measured by 18F-FDG PET/CT as a predictor of histopathologic response to neoadjuvant treatment in rectal cancer 429
Comparative evaluation of CT-based and respiratory-gated PET/CT-based planning target volume (PTV) in the definition of radiation treatment planning in lung cancer: preliminary results 379
Response to neoadjuvant therapy in locally advanced rectal cancer: assessment with diffusion-weighted MR imaging and 18FDG PET/CT 371
Intracavitary Brachytherapy in Cervical Carcinoma: The Role of F18-FDGPET in Treatment Planning 331
Efficacy of HT 7 point acupressure stimulation in the treatment of insomnia in cancer patients and in patients suffering from disorders other than cancer 325
A case-control study of Panicum Miliaceum in the treatment of cancer chemotherapy-induced alopecia 325
Radiotherapy-induced lymphocytopenia: changes in total lymphocyte count and in lymphocyte subpopulations under pelvic irradiation in gynecologic neoplasms 325
Epirubicin-vinorelbine intravenous combination followed by oral vinorelbine as first-line treatment in metastatic breast cancer 292
Possible involvement of prolactin in endocrine-resistant metastatic prostate cancer 291
Endocrine effects of erythropoietin in cancer patients 283
Brain irradiation-induced lymphocytosis predicts response in cancer patients with brain metastases 276
Effect of acupressure on nausea and vomiting induced by chemotherapy in cancer patients 274
Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study. 260
A progress study of 100 cancer patients treated by acupressure for chemotherapy-induced vomiting after failure with the pharmacological approach 258
Quality assurance of 3D-CRT: indications and difficulties in their applications. 247
The favorable prognostic significance of surgery-induced hyperprolactinemia in node-positive breast cancer patients: ten-year disease-free survival results 245
Quality indicators in radiotherapy 239
Efficacy of cancer chemotherapy in relation to the pretreatment number of lymphocytes in patients with metastatic solid tumors 213
Efficacy of IL-2 immunotherapy in metastatic renal cell carcinoma in relation to the psychic profile as evaluated using the Rorschach test 210
Enhancement of the efficacy of weekly low-dose taxotere by the long acting anti-prolactinemic drug cabergoline in pretreated metastatic breast cancer 198
Treatment with gefitinib in elderly patients or patients with poor performance status (PS) affected with non small cell lung carcinoma (NSCLC) 197
Biological response modifiers of cancer-related neuroendocrine disorders: efficacy of the long-term dopaminergic agonist cabergoline in the treatment of breast cancer-induced hyperprolactinemia 188
Treatment with gefitinib in elderly patients or patients with poor performance status (PS) affected with non small cell lung carcinoma (NSCLC) [Trattamento con Gefitinib nei pazienti anziani o con scarso performance status (PS), affetti da carcinoma polmonare non a piccole cellule (NSCLC)] 159
Totale 6.759
Categoria #
all - tutte 21.142
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.142


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022178 0 0 0 22 8 24 13 20 12 8 18 53
2022/2023625 48 229 66 54 49 79 6 33 36 0 16 9
2023/2024416 7 12 24 26 59 129 85 11 17 4 2 40
2024/2025676 56 75 11 25 54 45 31 20 66 103 74 116
2025/20262.332 269 95 156 151 348 144 326 133 181 181 179 169
2026/2027458 38 213 163 44 0 0 0 0 0 0 0 0
Totale 6.759